1. Arsenic sulfide reverses cisplatin resistance in non‐small cell lung cancer in vitro and in vivo through targeting PD‐L1. Issue 19 (1st September 2021) Authors: Tian, Wei; Sun, Yinping; Cheng, Yuping; Ma, Xiao; Du, Weina; Shi, Wenna; Guo, Qisen Journal: Thoracic cancer Issue: Volume 12:Issue 19(2021) Page Start: 2551 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CD44-targeting hydrophobic phosphorylated gemcitabine prodrug nanotherapeutics augment lung cancer therapy. (June 2022) Authors: Guo, Beibei; Wei, Jingjing; Wang, Jingyi; Sun, Yinping; Yuan, Jiandong; Zhong, Zhiyuan; Meng, Fenghua Journal: Acta biomaterialia Issue: Volume 145(2022) Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. MiRNA-148b regulates radioresistance in non-small lung cancer cells via regulation of MutL homologue 1. Issue 3 (30th June 2016) Authors: Zhai, Guangsheng; Li, Gaozhong; Xu, Bo; Jia, Tongfu; Sun, Yinping; Zheng, Jianbo; Li, Jianbin Journal: Bioscience reports Issue: Volume 36:Issue 3(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Small intestinal diverticulum with bleeding: Case report and literature review. Issue 9 (March 2018) Authors: Zhao, Lifang; Lu, Wei; Sun, Yinping; Liang, Junrong; Feng, Shanshan; Shi, Yongquan; Wu, Qiong; Wang, Jianhong; Wu, Kaichun Other Names: NA. section editor. Journal: Medicine Issue: Volume 97:Issue 9(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗